Comparing a new batch against an old one. A two-letter imprint is different in a way that may be nothing. Reagent tests are a screen, not an assay. They rule a family in or out and say nothing about dose.
Imprint databases are mostly US-centric. A confident hit for another market is still a guess. Currently on a two-letter imprint myself.
Imprint first, country second, colour last. And photograph both sides in daylight. Tolerance was my main issue with a two-letter imprint too.
Access to mugs should be on the clinical questionnaire.
Same here.
How do you get a clear photo of an imprint? Mine keep coming out blurry.
Ten percent cuts, of the current dose not the original. That is the arithmetic that keeps it survivable.
Same here.
Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.
The hologram is the least useful check because it is the one everybody makes.